Bancolombia SA
Change company Symbol lookup
Select an option...
CIB Bancolombia SA
TARA Protara Therapeutics Inc
SLAMU Slam Corp
SY So-Young International Inc
BHR Braemar Hotels & Resorts Inc
PLNT Planet Fitness Inc
GLDG GoldMining Inc
AUKUF ams OSRAM AG
DHI D R Horton Inc
ACEVW ACE Convergence Acquisition Equity Warrant Exp 30 Sep 2027 *W EXP 09/30/2027
Go


Based in Colombia
Company profile

Bancolombia S.A. (Bancolombia) is a financial institution engaged in providing a range of financial products and services to a diversified individual, corporate, and government customer base throughout Colombia, Latin America and the Caribbean region. The Bank operates through 10 segments: Banking Colombia, Banking Panama, Banking El Salvador, Leasing, Trust, Investment Banking, Brokerage, Off Shore and All other. It delivers its products and services through its regional network comprising Colombia's non-Government owned banking network, El Salvador's financial conglomerate by gross loans, Guatemala's bank, Panama's bank and off-shore banking subsidiaries in Panama, Cayman and Puerto Rico, as well as subsidiaries in Peru. The Bank and its subsidiaries offer Savings And Investment, Ahorro A La Mano, Financing, Mortgage Banking, Factoring, Financial and Operating Leases, Capital Markets, eTrading, Cash Management, Foreign Currency, Bancassurance, Investment Banking and Trust Services.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$30.90
Day's Change
0.07 (0.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
31.00
Day's Low
30.29
Volume
(Light)
Volume:
279,361

10-day average volume:
664,225
279,361

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AFRM, AKBA and LCID

1:25 pm ET April 28, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / April 28, 2022 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Affirm Holdings, Inc. (NASDAQ:AFRM)

Class Period: February 12, 2021 - February 10, 2022

Lead Plaintiff Deadline: April 29, 2022

The complaint alleges that throughout the class period Affirm Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Affirm's "buy now, pay-later" service facilitated excessive consumer debt, regulatory arbitrage, and data harvesting; (ii) the foregoing subjected Affirm to a heightened risk of regulatory scrutiny and enforcement action; (iii) Affirm maintained inadequate disclosure controls and procedures and internal control over financial reporting; (iv) accordingly, Affirm's tweet for its second quarter 2022 financial results contained selected metrics that made it appear that the Company had performed better than it actually did; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in AFRM: https://www.kleinstocklaw.com/pslra-1/affirm-holdings-inc-loss-submission-form?id=26498&from=1

Akebia Therapeutics, Inc. (NASDAQ:AKBA)

Class Period: June 28, 2018 - September 2, 2020

Lead Plaintiff Deadline: May 13, 2022

According to the complaint, Akebia Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's lead investigational product candidate, vadadustat, was not as safe in treating non-dialysis dependent chronic kidney disease patients with anemia as defendants had represented; (ii) as a result, defendants overstated the clinical prospects of a Phase 3 clinical program for vadadustat; (iii) accordingly, defendants also overstated vadadustat's overall commercial and regulatory prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in AKBA: https://www.kleinstocklaw.com/pslra-1/akebia-therapeutics-inc-loss-submission-form?id=26498&from=1

Lucid Group, Inc. (NASDAQ:LCID)

This lawsuit is on behalf of a class of all persons and entities who purchased or otherwise acquired Lucid common stock between November 15, 2021, and February 28, 2022, inclusive.

Lead Plaintiff Deadline: May 31, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Lucid's business and operations. Specifically, the Company overstated its production capabilities while concealing that "extraordinary supply chain and logistics challenges" were hampering Lucid's operations. As a result of the defendants' wrongful acts and omissions, and the significant decline in the market value of Lucid's common stock, Lucid investors have suffered significant damages.

Learn about your recoverable losses in LCID: https://www.kleinstocklaw.com/pslra-1/lucid-group-inc-loss-submission-form?id=26498&from=1

The Klein Law Firm, Thursday, April 28, 2022, Press release picture

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.

Empire State Building

350 Fifth Avenue

59th Floor

New York, NY 10118

jk@kleinstocklaw.com

Telephone: (212) 616-4899

Fax: (347) 558-9665

www.kleinstocklaw.com

SOURCE: The Klein Law Firm





View source version on accesswire.com:

https://www.accesswire.com/699328/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-AFRM-AKBA-and-LCID



comtex tracking

COMTEX_406393706/2457/2022-04-28T13:25:45

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.